Drug Prices, Is Everything You’ve Been Told Wrong? What if the real reason medicines cost so much isn’t what you’ve been told?
Failed to add items
Add to basket failed.
Add to wishlist failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
Drug Prices, Is Everything You’ve Been Told Wrong? What if the real reason medicines cost so much isn’t what you’ve been told?
-
Narrated by:
-
By:
In this episode, Dr. William Soliman sits down with Dr. Michael Ybarra, Chief Medical Officer of PhRMA, the pharmaceutical industry's largest trade organization, for a candid conversation on drug pricing, healthcare policy, pharmaceutical innovation, patient access, and the future of medicine.
Dr. Ybarra challenges some of the most common assumptions about prescription drug costs, explaining the role of PBMs, insurers, hospital markups, the 340B program, Medicare drug price negotiations, and the Inflation Reduction Act (IRA). The discussion also explores vaccine innovation, rare disease research, cancer breakthroughs, GLP-1 therapies, and the policies shaping the next generation of medical innovation.
Whether you’re a healthcare professional, policymaker, patient advocate, investor, or simply trying to understand why healthcare costs continue to rise, this episode offers an inside look at one of the most important debates in healthcare today.
Listen now to hear one of the leading physician voices from one of the largest trade organizations explain the forces shaping the future of medicine.
To learn more about The Will Soliman Podcast